Papers

1

Total Citations

18

H-Index

1

About

Huizhen Wang is a pioneering surgeon-researcher advancing the frontiers of robotic urologic oncology, with a primary focus on minimally invasive renal surgery. Her most impactful work evaluates the feasibility and safety of the novel KD-SR-01 robotic system for partial nephrectomy, a critical procedure for small renal masses. In a landmark 2022 study, Wang demonstrated that this new platform could achieve perioperative outcomes comparable to established systems, successfully treating 17 patients with tumors ≤4 cm. This contribution is especially significant as it expands access to robotic-assisted surgery by validating emerging technologies. With her top-cited paper garnering 18 citations and growing, Wang is establishing herself as a key voice in the adoption of next-generation surgical robotics. Her research directly addresses the pressing need for safe, effective alternatives in robotic surgery, offering promising data that could influence clinical practice and device development. For students and researchers in urology and surgical robotics, Wang’s work represents a vital bridge between innovation and patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Robot-Assisted Partial Nephrectomy with a New Robotic Surgical System: Feasibility and Perioperative Outcomes
18 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago